|Systematic (IUPAC) name|
|Biological half-life||3-5 hours|
|Molar mass||218.3 g/mol[[Script error: No such module "String".]]|
|Script error: No such module "collapsible list".|
Carphedon (C12H14N2O2, 2-(4-phenyl-2-oxopyrrolidin-1-yl)acetamide) is a derivative of the nootropic drug piracetam. It was developed in Russia, and a small number of low-scale clinical studies have shown possible links between prescription of carphedon and improvement in a number of encephalopathic conditions, including lesions of cerebral blood pathways, and certain types of glioma. It is also claimed to increase physical stamina and provide improved tolerance to cold. As a result, it appears on the lists of banned substances issued by the World Anti-Doping Agency. This list is applicable in all Olympic sports. As of 27 February 2006, the most recent confirmed case of carphedon use by a professional athlete is that of Russian biathlon Olympic silver medalist Olga Pyleva in the 2006 Winter Olympics, who was disqualified from attending further events following a positive drug test. She was subsequently banned from competition for two years. It may be noteworthy that Pyleva claims that carphedon was an unlisted ingredient of a Russian medication she was prescribed by her personal doctor (not a team doctor).
A former rider for Gerolsteiner, professional cyclist Danilo Hondo, tested positive to this banned substance in 2005.
While not widely available in the West, in Russia it is available as a prescription medicine under the brand name "Phenotropil". Packets of ten 100 mg pills are available for roughly 350 rubles (2009 price), or about 10 USD. It is typically prescribed as a general stimulant or to increase tolerance to cold and stress.
Cite error: Invalid
parameter "group" is allowed only.
<references />, or
<references group="..." />
- "Super Speed" from Vice Magazine's Russian issue
- *An interview with Danilo Hondo, 15-Jun-06* from Cyclingnews
- CNN, "Runners fail pre-Olympics doping tests", Retrieved on 2008-08-09